MGC Pharmaceuticals launches new CannEpil® App
MGC Pharmaceuticals Ltd (ASX:MXC) co-founder and MD Roby Zomer speaks to Proactive about the launch of its new CannEpil® app.
The app is designed to collect patient data and provides medical professionals with access to the International Library of Cannabinoids (ILC) as part of its collaboration with Royal Melbourne Institute of Technology (RMIT).
Zomer said: “This will help us to better understand how the medicine is working on the patient and eventually will help us to be more accurate in our clinical studies.”
Data collection on this scale will provide comprehensive information on cannabinoid treatments, driving growth in the industry and will assist the company to tailor future products and ensure their efficacy from early stages of development.